Question
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industryJohnson and Johnson (J&J) and Pfizer, Inc. ($
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industryJohnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts).
Balance Sheets ($ in millions, except per share data) | ||||||
J&J | Pfizer | |||||
Assets: | ||||||
Cash | $ | 5,377 | $ | 1,520 | ||
Short-term investments | 4,146 | 10,432 | ||||
Accounts receivable (net) | 6,574 | 8,775 | ||||
Inventories | 3,588 | 5,837 | ||||
Other current assets | 3,310 | 3,177 | ||||
Current assets | 22,995 | 29,741 | ||||
Property, plant, and equipment (net) | 9,846 | 18,287 | ||||
Intangibles and other assets | 15,422 | 68,747 | ||||
Total assets | $ | 48,263 | $ | 116,775 | ||
Liabilities and Shareholders' Equity: | ||||||
Accounts payable | $ | 4,966 | $ | 2,601 | ||
Short-term notes | 1,139 | 8,818 | ||||
Other current liabilities | 7,343 | 12,238 | ||||
Current liabilities | 13,448 | 23,657 | ||||
Long-term debt | 2,955 | 5,755 | ||||
Other long-term liabilities | 4,991 | 21,986 | ||||
Total liabilities | 21,394 | 51,398 | ||||
Capital stock (par and additional paid-in capital) | 3,120 | 67,050 | ||||
Retained earnings | 30,503 | 29,382 | ||||
Accumulated other comprehensive income (loss) | (590 | ) | 195 | |||
Less: Treasury stock and other equity adjustments | (6,164 | ) | (31,250 | ) | ||
Total shareholders' equity | 26,869 | 65,377 | ||||
Total liabilities and shareholders' equity | $ | 48,263 | $ | 116,775 | ||
Income Statements | ||||||
Net sales | $ | 41,862 | $ | 45,188 | ||
Cost of goods sold | 12,176 | 9,832 | ||||
Gross profit | 29,686 | 35,356 | ||||
Operating expenses | 19,763 | 28,486 | ||||
Other (income) expensenet | (385 | ) | 3,610 | |||
Income before taxes | 10,308 | 3,260 | ||||
Tax expense | 3,111 | 1,621 | ||||
Net income | $ | 7,197 | $ | 1,639 | * | |
Basic net income per share | $ | 2.42 | $ | 0.22 | ||
* | This is before income from discontinued operations. |
Evaluate and compare the two companies by responding to the following questions. |
Note: Because two-year comparative statements are not provided, you should use year-end balances in place of average balances as appropriate. |
Required: |
1-a. | Compute the receivables turnover for both the companies. (Round your answers to 2 decimal places.)
|
1-c. | Which of the two companies appears more efficient in collecting its accounts receivable?
|
2-a. | Compute the rate of return on assets for both the companies. (Round your percentage answers to 1 decimal place.) | |||||||||||||||
|
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started